BII Biocompatibles

 
TIDMBII 
 
FORM 8.3 
 
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON 
 
WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 
 
Rule 8.3 of the Takeover Code (the "Code") 
 
1. KEY INFORMATION 
 
(a) Identity of the person whose positions/ Aberforth Partners LLP on behalf of 
dealings are being disclosed:               discretionary clients 
 
(b) Owner or controller of interests and 
short positions disclosed, if different 
from 1(a): 
 
The naming of nominee or vehicle companies 
is insufficient 
 
(c) Name of offeror/offeree in relation to  Biocompatibles International plc 
whose relevant securities this form 
relates: 
 
Use a separate form for each offeror/ 
offeree 
 
(d) If an exempt fund manager connected 
with an offeror/offeree, state this and 
specify identity of offeror/offeree: 
 
(e) Date position held/dealing undertaken:  18 January 2011 
 
(f) Has the discloser previously disclosed, No 
or are they today disclosing, under the 
Code in respect of any other party to this 
offer? 
 
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE 
 
(a) Interests and short positions in the relevant securities of the offeror or 
offeree to which the disclosure relates following the dealing (if any) 
 
Class of relevant security:      Ordinary Shares 
 
                                 Interests              Short positions 
 
                                 Number       %         Number      % 
 
(1)Relevant securities owned and 2,724,230    6.92      Nil         0.00 
/or controlled: 
 
(2)Derivatives (other than 
options): 
 
(3)Options and agreements to 
purchase/sell: 
 
TOTAL:                           2,724,230    6.92      Nil         0.00 
 
All interests and all short positions should be disclosed. 
 
Details of any open derivative or option positions, or agreements to purchase 
or sell relevant securities, should be given on a Supplemental Form 8 (Open 
Positions). 
 
(b) Rights to subscribe for new securities (including directors' and other 
executive options) 
 
Class of relevant security in relation to N/A 
which subscription right exists: 
 
Details, including nature of the rights   N/A 
concerned and relevant percentages: 
 
If there are positions or rights to subscribe to disclose in more than one 
class of relevant securities of the offeror or offeree named in 1(c), copy 
table 2(a) or (b) (as appropriate) for each additional class of relevant 
security. 
 
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE 
 
(a) Purchases and sales 
 
Class of relevant      Purchase/sale  Number of securities   Price per unit 
security 
 
Ordinary Shares        Sale           1,000,000              384.0p 
 
(b) Derivatives transactions (other than options) 
 
Class of         Product     Nature of dealing  Number of    Price per unit 
relevant         description                    reference 
security                     e.g. opening/      securities 
                 e.g. CFD    closing a long/ 
                             short position, 
                             increasing/ 
                             reducing a long/ 
                             short position 
 
N/A 
 
(c) Options transactions in respect of existing securities 
 
(i) Writing, selling, purchasing or varying 
 
Class of Product     Writing,    Number of  Exercise Type e.g. Expiry   Option money 
relevant description purchasing, securities price    American, date 
security e.g. call   selling,    to which   per unit European           paid/ 
         option      varying     option              etc.               received 
                     etc.        relates 
                                                                        per unit 
 
N/A 
 
(ii) Exercising 
 
Class of         Product description Number of          Exercise price per unit 
relevant                             securities 
security         e.g. call option 
 
N/A 
 
(d) Other dealings (including subscribing for new securities) 
 
Class of         Nature of dealing   Details            Price per unit 
relevant s 
ecurity          e.g. subscription,                     (if applicable) 
 
                 conversion 
 
N/A 
 
The currency of all prices and other monetary amounts should be stated. 
 
Where there have been dealings in more than one class of relevant securities of 
the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as 
appropriate) for each additional class of relevant security dealt in. 
 
4. OTHER INFORMATION 
 
(a) Indemnity and other dealing arrangements 
 
Details of any indemnity or option arrangement, or any agreement or 
understanding, formal or informal, relating to relevant securities which may be 
an inducement to deal or refrain from dealing entered into by the person making 
the disclosure and any party to the offer or any person acting in concert with 
a party to the offer: 
 
If there are no such agreements, arrangements or understandings, state "none" 
 
None 
 
(b) Agreements, arrangements or understandings relating to options or 
derivatives 
 
Details of any agreement, arrangement or understanding, formal or informal, 
between the person making the disclosure and any other person relating to: 
 
(i) the voting rights of any relevant securities under any option; or 
 
(ii) the voting rights or future acquisition or disposal of any relevant 
securities to which any derivative is referenced: 
 
If there are no such agreements, arrangements or understandings, state "none" 
 
None 
 
(c) Attachments 
 
Is a Supplemental Form 8    No 
 
(Open Positions) attached? 
 
Date of disclosure:         19 January 2011 
 
Contact name:               Pauline Robson, for Aberforth Partners LLP 
 
Telephone number:           0131-220-0733 
 
Public disclosures under Rule 8 of the Code must be made to a Regulatory 
Information Service and must also be emailed to the Takeover Panel at 
monitoring@disclosure.org.uk . The Panel's Market Surveillance Unit is 
available for consultation in relation to the Code's dealing disclosure 
requirements on +44 (0)20 7638 0129. 
 
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk . 
 
 
 
END 
 

Biocompatibles (LSE:BII)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024

Biocompatibles (LSE:BII)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024